Millipore Sigma Vibrant Logo

444800 Meloxicam - CAS 71125-38-7 - Calbiochem

A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC₅₀ = 4.7 µM) relative to COX-1 (IC₅₀ = 36.6 µM).

Meloxicam - CAS 71125-38-7 - Calbiochem: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide

Primary Target: COX-2
View Products on Sigmaaldrich.com
444800
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
71125-38-7C₁₄H₁₃N₃O₄S₂

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
444800-100MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 100 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC50 = 4.7 µM) relative to COX-1 (IC50 = 36.6 µM). Also inhibits the growth of colorectal cancer cells in vitro.
      Catalogue Number444800
      Brand Family Calbiochem®
      Synonyms4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
      References
      ReferencesBlanco, F.J., et al. 1999. J. Rheumatol. 26, 1366.
      Davies, N.M., and Skjodt, N.M. 1999. Clin. Pharmacokinet. 36, 115.
      Goldman, A.P., et al. 1998. Carcinogenesis 19, 2195.
      Product Information
      CAS number71125-38-7
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₁₄H₁₃N₃O₄S₂
      Chemical formulaC₁₄H₁₃N₃O₄S₂
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCOX-2
      Primary Target IC<sub>50</sub>4.7 µM, 36.6 µM against the inducible isoform of COX-2 relative to COX-1, respectively
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      444800-100MG 04055977186147

      Documentation

      Meloxicam - CAS 71125-38-7 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Meloxicam - CAS 71125-38-7 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      444800

      Referencias bibliográficas

      Visión general referencias
      Blanco, F.J., et al. 1999. J. Rheumatol. 26, 1366.
      Davies, N.M., and Skjodt, N.M. 1999. Clin. Pharmacokinet. 36, 115.
      Goldman, A.P., et al. 1998. Carcinogenesis 19, 2195.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-May-2008 RFH
      Synonyms4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide
      DescriptionA cell-permeable, non-steroidal, anti-inflammatory drug (NSAID) of the oxicam family that preferentially inhibits the inducible isoform of cyclooxygenase-2 (COX-2; IC50 = 4.7 µM) relative to cyclooxygenase-1 (COX-1; IC50 = 36.6 µM). Also inhibits the growth of colorectal cancer cells in vitro.
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number71125-38-7
      Chemical formulaC₁₄H₁₃N₃O₄S₂
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 3 months at -20°C.
      Toxicity Standard Handling
      Merck USA index14, 5826
      ReferencesBlanco, F.J., et al. 1999. J. Rheumatol. 26, 1366.
      Davies, N.M., and Skjodt, N.M. 1999. Clin. Pharmacokinet. 36, 115.
      Goldman, A.P., et al. 1998. Carcinogenesis 19, 2195.